Doctor profile · Federal record
Dr. ABDEL-GHANIE ABU-SAMRA, M.D
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Critical Care Medicine (Internal Medicine) Physician · WICHITA, KS
- NPI 1134383177
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 20 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3311 E MURDOCK ST
WICHITA, KS 672083054
(316) 689-9325
fax (316) 689-9769 - Mailing address
-
PO BOX 8035
WICHITA, KS 672080035
Credentials & registration
- NPI registered
- July 2008 — 18 yrs on file
- Profile last updated
- June 20, 2014
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Kansas #04-37311
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1134383177. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,633
Distinct HCPCS
10
Medicare allowed
$595,112
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2182 |
Injection, mepolizumab, 1 mg | 4,800 | 17 | $29 | |
J2357 |
Injection, omalizumab, 5 mg | 3,165 | 12 | $38 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 468 | 158 | $112 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 376 | 282 | $119 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 328 | 160 | $74 | |
94729 |
Test to examine how well the lungs exchange gases | 273 | 262 | $52 | |
94010 |
Test to measure expiratory airflow and volume | 256 | 227 | $25 | |
94726 |
Test to determine lung volumes using sensors | 252 | 244 | $50 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 209 | 195 | $84 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 188 | 188 | $156 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 209. This provider delivers 56× the peer median.Open Payments
Industry payments received
All-time total
$19,022
Transactions
32
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Inari Medical, Inc. | 16 | $17,009.33 | |
| INTUITIVE SURGICAL, INC. | 8 | $1,061.11 | |
| AstraZeneca Pharmaceuticals LP | 3 | $371.11 | |
| Pulmonx Corporation | 1 | $134.61 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $124.99 | |
| GENZYME CORPORATION | 1 | $124.99 | |
| GlaxoSmithKline, LLC. | 1 | $99.97 | |
| Actelion Pharmaceuticals US, Inc. | 1 | $95.87 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,979
Patients
776
Total drug cost
$1,184,491
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 664 | 130 | $524,044 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 397 | 77 | $195,757 |
| Prednisone | Generic | 262 | 108 | $1,584 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 226 | 77 | $6,057 |
| Azelastine Hcl | Generic | 223 | 100 | $8,822 |
| Montelukast Sodium | Generic | 175 | 42 | $2,046 |
| Incruse Ellipta (Umeclidinium Bromide) | Brand | 138 | 25 | $81,277 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 137 | 30 | $78,672 |
| Azithromycin | Generic | 132 | 33 | $2,575 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 132 | 21 | $84,894 |